Skip to main content

Advertisement

Log in

Pneumothorax After Transbronchial Biopsy in Pulmonary Fibrosis: Lessons from the Multicenter COMET Trial

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Purpose

Some patients with diffuse interstitial lung disease (ILD) undergo bronchoscopy with transbronchial biopsy (TBB) as part of their diagnostic evaluation. It is unclear what the incidence and risk factors for pneumothorax (PTX) following TBB are in this patient population.

Methods

Ninety-seven subjects with pulmonary fibrosis who underwent a research bronchoscopy with TBB as part of the multicenter correlating outcomes with biochemical markers to estimate time-progression in idiopathic pulmonary fibrosis (COMET) trial were retrospectively reviewed. We compared subjects who developed a PTX during research bronchoscopy with TBB versus those who did not.

Results

Seven patients (7.2%) experienced a PTX during research bronchoscopy with TBB. Subjects who experienced PTX during TBB had significantly lower DLCO percent predicted (29 ± 8 vs. 45 ± 15, P = 0.006) and had lower resting room air saturation of peripheral oxygen (SPO2) on 6-min walk testing (91 ± 10 vs. 95 ± 3, P = 0.02). No differences between groups were found with respect to age, gender, race, BMI, HRCT characteristics, or the number of transbronchial biopsies performed.

Conclusion

The incidence of PTX following research bronchoscopy with TBB in patients with pulmonary fibrosis was found to be 7.2% in this study. Patients who developed a pneumothorax had greater impairments in gas exchange at baseline evidenced by a lower DLCO  % predicted and a lower resting room air SPO2 compared with subjects without PTX as a complication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

6MWT:

Six-minute walk test

BAL:

Bronchoalveolar lavage

BMI:

Body mass index

COMET:

Correlating outcomes with biochemical markers to estimate time-progression in IPF

COPD:

Chronic obstructive pulmonary disease

DLCO :

Diffusion capacity of carbon monoxide

FEV1 :

Forced expiratory volume in the first second

FVC:

Forced vital capacity

HRCT:

High-resolution computed tomography

ILD:

Interstitial lung disease

IPF:

Idiopathic pulmonary fibrosis

NHANES:

National health and nutrition examination survey

SPO2 :

Saturation of peripheral oxygen

PTX:

Pneumothorax

TBB:

Transbronchial biopsy

UIP:

Usual interstitial pneumonia

References

  1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183(6):788–824

    Article  PubMed  PubMed Central  Google Scholar 

  2. American Thoracic Society (2002) European Respiratory Society. American thoracic Society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165(2):277–304

    Article  Google Scholar 

  3. Pue CA, Pacht ER (1995) Complications of fiberoptic bronchoscopy at a university hospital. Chest 107(2):430–432

    Article  CAS  PubMed  Google Scholar 

  4. Selman M, King TE, Pardo A (2001) American Thoracic Society, European Respiratory Society, American College of Chest Physicians. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134(2):136–151

    Article  CAS  PubMed  Google Scholar 

  5. Costabel U, King TE (2001) International consensus statement on idiopathic pulmonary fibrosis. Eur Respir J 17(2):163–167

    Article  CAS  PubMed  Google Scholar 

  6. Boskovic T, Stojanovic M, Stanic J et al (2014) Pneumothorax after transbronchial needle biopsy. Thorac Dis. 6:427–434

    Google Scholar 

  7. Hankinson JL, Odencrantz JR, Fedan KB (1999) Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159(1):179–187

    Article  CAS  PubMed  Google Scholar 

  8. Crapo RO, Morris AH (1981) Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 123(2):185–189

    CAS  PubMed  Google Scholar 

  9. Izbicki G, Shitrit D, Yarmolovsky A, Bendayan D, Miller G, Fink G et al (2006) Is routine chest radiography after transbronchial biopsy necessary?: a prospective study of 350 cases. Chest 129(6):1561–1564

    Article  PubMed  Google Scholar 

  10. Puar HS, Young RC Jr, Armstrong EM (1985) Bronchial and transbronchial lung biopsy without fluoroscopy in sarcoidosis. Chest 87(3):303–306

    Article  CAS  PubMed  Google Scholar 

  11. Joyner LR, Scheinhorn DJ (1975) Transbronchial forceps lung biopsy through the fiberoptic bronchoscope: diagnosis of diffuse pulmonary disease. Chest 67(5):532–535

    Article  CAS  PubMed  Google Scholar 

  12. de Fenoyl O, Capron F, Lebeau B, Rochemaure J (1989) Transbronchial biopsy without fluoroscopy: a 5 year experience in outpatients. Thorax 44(11):956–959

    Article  PubMed  PubMed Central  Google Scholar 

  13. Rittirak W, Sompradeekul S (2007) Diagnostic yield of fluoroscopy-guided transbronchial lung biopsy in non-endobronchial lung lesion. J Med Assoc Thai 90(Suppl 2):68–73

    PubMed  Google Scholar 

  14. Anders GT, Johnson JE, Bush BA, Matthews JI (1988) Transbronchial biopsy without fluoroscopy. A 7 year perspective. Chest 94(3):557–560

    Article  CAS  PubMed  Google Scholar 

  15. Milman N, Faurschou P, Munch EP, Grode G (1994) Transbronchial lung biopsy through the fibre optic bronchoscope. Results and complications in 452 examinations. Respir Med 88(10):749–753

    Article  CAS  PubMed  Google Scholar 

  16. Herf SM, Suratt PM (1978) Complications of transbronchial lung biopsies. Chest 73(5 Suppl):759–760

    Article  CAS  PubMed  Google Scholar 

  17. Hernandez Blasco L, Sanchez Hernandez IM, Villena Garrido V, de Miguel Poch E, Nunez Delgado M, Alfaro Abreu J (1991) Safety of the transbronchial biopsy in outpatients. Chest 99(3):562–565

    Article  CAS  PubMed  Google Scholar 

  18. Hernandez Borge J, Alfageme Michavila I, Munoz Mendez J, Villagomez Cerrato R, Campos Rodriguez F, Pena Grinan N (1998) Factors related to diagnostic yield and complications of transbronchial biopsy. Arch Bronconeumol 34(3):133–141

    Article  CAS  PubMed  Google Scholar 

  19. Ellis JH Jr (1975) Transbronchial lung biopsy via the fiberoptic bronchoscope. Experience with 107 consecutive cases and comparison with bronchial brushing. Chest 68(4):524–532

    Article  PubMed  Google Scholar 

  20. Mitchell DM, Emerson CJ, Collins JV, Stableforth DE (1981) Transbronchial lung biopsy with the fibreoptic bronchoscope: analysis of results in 433 patients. Br J Dis Chest. 75(3):258–262

    Article  CAS  PubMed  Google Scholar 

  21. Frazier WD, Pope TL Jr, Findley LJ (1990) Pneumothorax following transbronchial biopsy. low diagnostic yield with routine chest roentgenograms. Chest 97(3):539–540

    Article  CAS  PubMed  Google Scholar 

  22. Sinha S, Guleria R, Pande JN, Pandey RM (2004) Bronchoscopy in adults at a tertiary care centre: indications and complications. J Indian Med Assoc 102(3):152–156

    PubMed  Google Scholar 

  23. Ahmad M, Livingston DR, Golish JA, Mehta AC, Wiedemann HP (1986) The safety of outpatient transbronchial biopsy. Chest 90(3):403–405

    Article  CAS  PubMed  Google Scholar 

  24. Ulmeanu R, Mihaltan F, Crisan E, Alexe M, Grigore P, Andreescu I et al (2007) Practical issues of transbronchial lung biopsy (TLB) in pneumology. Pneumologia 56(2):59–67

    PubMed  Google Scholar 

  25. Hanson RR, Zavala DC, Rhodes ML, Keim LW, Smith JD (1976) Transbronchial biopsy via flexible fiberoptic bronchoscope; results in 164 patients. Am Rev Respir Dis 114(1):67–72

    CAS  PubMed  Google Scholar 

  26. Alzeer AH, Al-Otair HA, Al-Hajjaj MS (2008) Yield and complications of flexible fiberoptic bronchoscopy in a teaching hospital. Saudi Med J 29(1):55–59

    PubMed  Google Scholar 

  27. Clark RA, Gray PB, Townshend RH, Howard P (1977) Transbronchial lung biopsy: a review of 85 cases. Thorax 32(5):546–549

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Pereira W Jr, Kovnat DM, Snider GL (1978) A prospective cooperative study of complications following flexible fiberoptic bronchoscopy. Chest 73(6):813–816

    Article  PubMed  Google Scholar 

  29. Jain P, Sandur S, Meli Y, Arroliga AC, Stoller JK, Mehta AC (2004) Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest 125(2):712–722

    Article  PubMed  Google Scholar 

  30. Koonitz CH, Joyner LR, Nelson RA (1976) Transbronchial lung biopsy via the fiberoptic bronchoscope in sarcoidosis. Ann Intern Med 85(1):64–66

    Article  CAS  PubMed  Google Scholar 

  31. Kopp C, Perruchoud A, Heitz M, Dalquen P, Herzog H (1983) Transbronchial lung biopsy in sarcoidosis. Klin Wochenschr 61(9):451–454

    Article  CAS  PubMed  Google Scholar 

  32. Chen W, Ji C, Li Y, Xu D (1990) Diagnostic value of transbronchial lung biopsy in diffuse or peripheral lung lesions. Hua Xi Yi Ke Da Xue Xue Bao 21(3):330–333

    CAS  PubMed  Google Scholar 

  33. Cazzadori A, Di Perri G, Todeschini G, Luzzati R, Boschiero L, Perona G et al (1995) Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised patients. Chest 107(1):101–106

    Article  CAS  PubMed  Google Scholar 

  34. Sindhwani G, Shirazi N, Sodhi R et al (2015) Transbronchial lung biopsy in patients with diffuse parenchymal lung disease without ‘idiopathic pulmonary fibrosis pattern’ on HRCT scan- Experience from a tertiary care center of North India. Lung India 32:453–456

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by the National Institutes of Health (Grant 1RC2HL101740-01).

Author information

Authors and Affiliations

Authors

Consortia

Contributions

Dr. Galli and Dr. Panetta contributed to the study concept and design, analysis and interpretation of data, and drafting and revision of the manuscript. Dr. Gaeckle performed statistical analysis, interpretation of data, and figure rendering. Dr. Criner served as the guarantor of the paper, contributed to the study concept and design, analysis and interpretation of the data, critical revision of the manuscript for important intellectual content, and approval of the final manuscript. Dr. Martinez, Dr. Bethany Moore, Dr. Thomas Moore, Dr. Courey, and Dr. Flaherty contributed to the study concept and design, and analysis and interpretation of the data.

Corresponding author

Correspondence to Jonathan A. Galli.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 47 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Galli, J.A., Panetta, N.L., Gaeckle, N. et al. Pneumothorax After Transbronchial Biopsy in Pulmonary Fibrosis: Lessons from the Multicenter COMET Trial. Lung 195, 537–543 (2017). https://doi.org/10.1007/s00408-017-0028-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-017-0028-z

Keywords

Navigation